Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

Jason B. Dinoso, S. Y. Kim, Ann Wiegand, +15

Proceedings of the National Academy of Sciences

Hiv-1 RnaTreatment And PreventionHuman RetrovirusTreatment IntensificationResidual Viremia +13

Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation

Hung‐Chih Yang, Sifei Xing, Liang Shan, +10

Journal of Clinical Investigation

EngineeringReverse LatencyImmunologyMolecular BiologyImmunotherapy +18

A Simian Immunodeficiency Virus-Infected Macaque Model To Study Viral Reservoirs That Persist during Highly Active Antiretroviral Therapy

Jason B. Dinoso, S. Alireza Rabi, Joel N. Blankson, +5

Journal of Virology

Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle

Ahmad R. Sedaghat, Jason B. Dinoso, Lin Shen, +2

Proceedings of the National Academy of Sciences

Decay DynamicsImmunologyViral DynamicAntiviral DrugTranslational Medicine +18

Reovirus Nonstructural Protein μNS Recruits Viral Core Surface Proteins and Entering Core Particles to Factory-Like Inclusions

Teresa J. Broering, Jong‐Hwa Kim, Cathy L. Miller, +4

Journal of Virology

Virus StructureFactory-like InclusionsViral ReplicationMolecular VirologyViral Polymerase Mechanism +11

Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against <i>Staphylococcus aureus</i> in mice

Sophie M. Lehar, Johnny Gutierrez, Carrie M. Rosenberger, +9

mAbs

ImmunologyPharmacotherapyAntimicrobial ChemotherapyUnconjugated Dmdna31Pharmacodynamic Modeling +17

T Cell Dynamics and the Response to HAART in a Cohort of HIV‐1–Infected Elite Suppressors

Ahmad R. Sedaghat, Darius A. Rastegar, Karen A. O’Connell, +3

Clinical Infectious Diseases

Elite ControllersImmune ActivationImmunodeficienciesImmunologyCd4 T Cell Responses +17

A Comparison of Viral Loads between HIV‐1–Infected Elite Suppressors and Individuals Who Receive Suppressive Highly Active Antiretroviral Therapy

Jason B. Dinoso, Scott Y. H. Kim, Robert F. Siliciano, +1

Clinical Infectious Diseases

Hiv‐1–infected Elite SuppressorsTreatment And PreventionHuman RetrovirusImmunodeficienciesImmunology +11

A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection

Alessander Guimaraes, Yi Cao, Kyu Hong, +13

Clinical Infectious Diseases

A tRNATRP gene mediates the suppression of cbs2-223 previously attributed to ABC1/COQ8

Edward J. Hsieh, Jason B. Dinoso, Catherine F. Clarke

Biochemical and Biophysical Research Communications

Natural SciencesGeneticsTrnatrp GeneGene StructureMolecular Biology +6